The mRNA level of HELLS was evaluated in lung cancer using GEPIA analysis, and the expression of HELLS in lung cancer tissues was significantly higher than in adjacent tissues (p < 0.05) (Fig. 5G). This evidence concerns the gene HELLS and lung carcinoma.